iifl-logo

PGIM India Healthcare Fund Regular G

PGIM India Healthcare Fund Regular G

Fund Name

PGIM India Mutual Fund

Scheme Name

PGIM India Healthcare Fund Regular G

AMC

PGIM India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

19-Nov-2024

Fund Manager

Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

103.24

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

PGIM India Healthcare Fund Regular G - Nav Details

Nav Date

:  22-Jul-2026

NAV [Rs.]

:  11.65

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Regular G- NAV Chart

PGIM India Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.34
4.29
16.96
23.54
16.38
-
-
9.85
Category Avg
0.79
5.72
15.98
21.88
13.08
22.43
14.72
17.41
Category Best
1.53
7.42
20.67
31.09
21.27
26.33
18.03
32.03
Category Worst
-0.12
3.21
8.87
11.26
4.9
18.84
11.09
6.25

PGIM India Healthcare Fund Regular G- Latest Dividends

No Records Found

PGIM India Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Zydus Lifesci.13,355

Out

InName Of The CompanyNo Of Shares
PB Fintech.7,678

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.866018811.21
EquityDivi's Lab.Pharmaceuticals & Biotechnology9.14143399.43
EquityMax HealthcareHealthcare Services6.52595646.72
EquityAster DM Health.Healthcare Services6.41843796.61
EquityJ B Chemicals &Pharmaceuticals & Biotechnology6.40287856.60
EquityAjanta PharmaPharmaceuticals & Biotechnology5.56167655.73
EquityMankind PharmaPharmaceuticals & Biotechnology5.19210455.35
EquityKrishna Institu.Healthcare Services4.12522474.25
EquityRubicon ResearchPharmaceuticals & Biotechnology3.99293704.12
EquityNeuland Labs.Pharmaceuticals & Biotechnology3.1917743.29
EquityDr Lal PathlabsHealthcare Services3.10194203.19
EquityNavin Fluo.Intl.Chemicals & Petrochemicals3.0941523.19
EquityDr Reddy's LabsPharmaceuticals & Biotechnology2.63200212.71
EquitySai LifePharmaceuticals & Biotechnology2.60217562.68
EquityTorrent Pharma.Pharmaceuticals & Biotechnology2.5857602.66
EquityCiplaPharmaceuticals & Biotechnology2.57181112.65
EquityAbbott IndiaPharmaceuticals & Biotechnology2.5610382.64
EquityJupiter Life LinHealthcare Services2.06149902.12
EquityAnthem BiosciencPharmaceuticals & Biotechnology2.05274572.11
EquityGlobal HealthHealthcare Services1.85145511.91
EquityPfizerPharmaceuticals & Biotechnology1.6538481.70
EquityZydus Lifesci.Pharmaceuticals & Biotechnology1.44133551.48
EquityFortis Health.Healthcare Services1.41151601.45
EquityLupinPharmaceuticals & Biotechnology1.3356901.37
EquityICICI LombardInsurance1.0361181.06
EquityDr Agarwal's HeaHealthcare Services0.97209401.00
EquityOrchid PharmaPharmaceuticals & Biotechnology0.97102851.00
EquityLenskart Solut.Retailing0.67135010.69
EquityDr Agarwal's EyeHealthcare Services0.499940.50
EquitySagilityIT - Services0.471226240.48

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
26,639.93
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.